TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: SPINA-GT index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: impaired insulin secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: changes in insulin sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Proportion of men with clinically significant PCa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Accuracy of mp‐MRI for the diagnosis of PCa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: mean VAS pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduced FA and increased D values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Coclustering of AChR with rapsyn
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postanaesthesia behaviour assessment scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cervical subluxation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Axial distraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breast cancer events (BC events)
Endpoint domain: Mortality/survival
Primary endpoint: Post-landmark Breast Cancer Free Interval (BCFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Availability of fruits and vegetables (FV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Availability of sugar-sweetened beverages (SSBs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TV viewing during family meals
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cervical maturity stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positivity rates of IGFBP‐1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Indication for cesarean section
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: decreased disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Symptom improvement on Urogenital Distress Inventory Short Form change scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite score of lesion border delineation, contrast enhancement, and internal morphology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful drainage rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean VAS pain scores in response to cough at 24th hour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean VAS pain scores during rest at 0 to 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morphine consumption at 0 to 2 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Colonization of C albicans in buccal mucosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Production of phospholipase from C albicans isolates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported stuttering severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean medication costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: net health benefits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Maximal arterial dilation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximal venous dilation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean heartburn score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of AUR and/or BPH related surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: NFL concentration in CSF, serum, and plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Sputum mediator concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ACQ and/or AQLQ scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postoperative visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Early reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Late skin reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Success rate of atrioventricular nodal modification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mapping duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coagulum formation on the catheter tip
Endpoint domain: Adverse events/effects
Primary endpoint: Statistically significant median increase in SSV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Statistically significant median increase in MV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in 6MWT posttraining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: moisture levels of the external ear canal skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: rAI (reflected Aortic Impedance)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Neurocognitive outcomes
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Quality of survival
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Circulating markers of bone resorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum levels of inflammatory biomarkers (hs-CRP, TNF-α, IL-6, MMP-3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Expression of endothelial adhesion molecules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Superoxide production in circulating neutrophils
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Effectiveness differential
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of women undelivered 7 days after admission
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Proportion of infants admitted to special care nurseries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Fat mass difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fat free mass difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Moderate to vigorous physical activities difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: real time of 'fdp' in hours per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: contentment in reference to the available supports
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean number of CSBMs per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of patients reaching a mean number of at least three CSBMs per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Quality of life improvement (PAC-QoL questionnaire)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pulmonary (67)Ga uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-efficacy for exercise competence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: behavioural processes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patterns of stage change
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: perception of physical ability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: sense of liveliness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvements in social problem-solving
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Changes in criminal attitudes
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Healing/improving the CAF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of total side effects
Endpoint domain: Adverse events/effects
Primary endpoint: muscular strength and endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: range identification accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response accuracy to alcohol-related stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response time to go-trials
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary excretion of 3-hydroxyisovaleric acid (3-HIA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Urinary excretion of 3-hydroxyisovaleryl-carnitine (3-HIA-carnitine)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Urinary excretion of bisnorbiotin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Amylase drainage level on postoperative day 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative creatine kinase isoenzyme MB (CK-MB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiac Troponin I (cTnI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: sensitivity of the UBT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: specificity of the UBT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 13C/12C ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced medial frontal rs-FC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: BDI remission rates
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: QIDS‐C overall effect sizes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and severity of postoperative sore throat
Endpoint domain: Adverse events/effects
Primary endpoint: occurrence of major thrombotic or bleeding events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of women with regular menstrual cycles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hirsutism severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bone health
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean soluble oxalate content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Availability of oxalate extracted from tea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Positive nuclear cardiology scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CO2 reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return to clinic with male partner
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: awareness of guidelines
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: knowledge of where to find guidelines
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: access to guidelines
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Progression to diabetes
Endpoint domain: Adverse events/effects
Primary endpoint: Plasma sE-selectin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: NF-κB p65 levels in PBMC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: SIRT1 levels in PBMC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Activity avoidance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time to corneal erosion disappearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Low-flow-mediated constriction (L-FMC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Oral subjective symptom scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mortality rates of infants' accidental suffocation
Endpoint domain: Mortality/survival
Primary endpoint: Mortality rates of drowning in children aged 1-4
Endpoint domain: Mortality/survival
Primary endpoint: Bronchoconstriction inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: postoperative WOMAC score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IMR scale (clinician version) score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RMQ score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dropout rate from treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: total PCA infusion volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of rescue injections
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Low CD4 cell counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: General comfort scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Self‐rating anxiety scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mRS score
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Bone-implant contact percentage (BIC%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to first compressions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: correct hand positioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ad libitum energy intake (EI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pediatric asthma caregiver quality-of-life score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: asthma-related urgent health services use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: antifracture effect of HRT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dietary satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Increased appetite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: performance improvement over days between sessions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of novel P. vivax populations in patients with recurrent infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: evaluation of appearance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: primary graft patency rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence rate of postoperative hematoma
Endpoint domain: Adverse events/effects
Primary endpoint: Mean fertilization rate per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Mean cleavage rate per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: TNF‐α and IL‐1β levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: flow mediated dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: basal artery diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: impairment of inguinal sensibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recovery of daily activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: mRNA expression for IGF-I
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mRNA expression for IGF-II
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: phosphorylation state of 4E-BP1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ALT levels in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: gamma-GT levels in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: expression of HBsAg in liver
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: neck muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pharmacokinetics of tapentadol ER
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GOS scores higher than 3
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: rates of dysphoria
Endpoint domain: Adverse events/effects
Primary endpoint: rates of depressive symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: rates of extrapyramidal symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: IC-DCR (Intracranial Disease Control Rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical cure rate on D3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical cure rate on D7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: B‐QOL scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cessation of vaginal bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Descent of the uterine fundus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Incomplete uterine involution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Prealbumin values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Interferon gamma (INF‐γ) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Median duration of breastfeeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shift from T(H)2 immunity toward T(H)1 immunity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cytokine and chemokine levels (IFN-gamma, CXCL9, CXCL10, IL-5, CCL17, CCL22)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Clinically significant allergic reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Mean testosterone level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Menstrual disturbances
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Development of PCOS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Problem behaviors
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total problems
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Safety and tolerability of CEPO
Endpoint domain: Adverse events/effects
Primary endpoint: mean half-time for gastric emptying of solids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Vaccine efficacy against cervical intraepithelial neoplasia grade I
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Vaccine efficacy against vulvar intraepithelial neoplasia grade I
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Vaccine efficacy against condyloma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Femoral neck BMC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relief of symptoms and signs postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for reoperation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Total Bilirubin (TB) trajectory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of hyperbilirubinemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes